Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / *W EXP 02/10/202
-
Total 13F shares
-
4,159,614
-
Share change
-
+4,113,060
-
Total reported value
-
$11,088,000
-
Price per share
-
$2.67
-
Number of holders
-
28
-
Value change
-
+$10,964,009
-
Number of buys
-
27
Institutional Holders of NUVATION BIO INC - *W EXP 02/10/202 (NUVBWS) as of Q1 2021
As of 31 Mar 2021,
NUVATION BIO INC - *W EXP 02/10/202 (NUVBWS) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,159,614 shares.
The largest 10 holders included
683 Capital Management, LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, FRANKLIN RESOURCES INC, ADAGE CAPITAL PARTNERS GP, L.L.C., BOXER CAPITAL, LLC, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, Castle Creek Arbitrage, LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), and Walleye Capital LLC.
This page lists
28
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.